Wednesday, December 18, 2024 The EN7 (DCGOG PORTEC-3) trial: Randomized Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma has been permanently closed. This randomized phase III trial was studying chemotherapy and radiation therapy to see how well they work compared with radiation therapy alone in treating patients with high-risk, stage I, stage II, or stage III endometrial cancer.For more information please visit the EN7 members trial page>
